These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 25087772)

  • 1. Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis.
    Wang H; Dong J; Shi P; Liu J; Zuo L; Li Y; Gong J; Gu L; Zhao J; Zhang L; Zhang W; Zhu W; Li N; Li J
    Immunology; 2015 Feb; 144(2):254-62. PubMed ID: 25087772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.
    Su L; Nalle SC; Shen L; Turner ES; Singh G; Breskin LA; Khramtsova EA; Khramtsova G; Tsai PY; Fu YX; Abraham C; Turner JR
    Gastroenterology; 2013 Aug; 145(2):407-15. PubMed ID: 23619146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Non-digestible Polysaccharides Ameliorate Intestinal Epithelial Barrier Dysfunction in IL-10 Knockout Mice.
    Wang H; Shi P; Zuo L; Dong J; Zhao J; Liu Q; Zhu W
    J Crohns Colitis; 2016 Sep; 10(9):1076-86. PubMed ID: 26944415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-mouse CD52 monoclonal antibody ameliorates iron-deficient anaemia in IL-10 knockout mice.
    Wang H; Dong J; Zuo L; Liu J; Zhu W; Li Y; Gu L; Zhao J; Zhang L; Gong J; Zhang W; Li N; Li J
    Br J Nutr; 2014 Mar; 111(6):987-95. PubMed ID: 24160470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DHA protects against experimental colitis in IL-10-deficient mice associated with the modulation of intestinal epithelial barrier function.
    Zhao J; Shi P; Sun Y; Sun J; Dong JN; Wang HG; Zuo LG; Gong JF; Li Y; Gu LL; Li N; Li JS; Zhu WM
    Br J Nutr; 2015 Jul; 114(2):181-8. PubMed ID: 26104043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myosin light chain kinase expression induced via tumor necrosis factor receptor 2 signaling in the epithelial cells regulates the development of colitis-associated carcinogenesis.
    Suzuki M; Nagaishi T; Yamazaki M; Onizawa M; Watabe T; Sakamaki Y; Ichinose S; Totsuka M; Oshima S; Okamoto R; Shimonaka M; Yagita H; Nakamura T; Watanabe M
    PLoS One; 2014; 9(2):e88369. PubMed ID: 24520376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEW2871 protects from experimental colitis through reduced epithelial cell apoptosis and improved barrier function in interleukin-10 gene-deficient mice.
    Dong J; Wang H; Zhao J; Sun J; Zhang T; Zuo L; Zhu W; Gong J; Li Y; Gu L; Li J
    Immunol Res; 2015 Mar; 61(3):303-11. PubMed ID: 25588868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-mouse CD52 Treatment Ameliorates Colitis through Suppressing Th1/17 Mediated Inflammation and Promoting Tregs Differentiation in IL-10 Deficient Mice.
    Liu J; Wang H; Li Y; Shi P; Gong J; Gu L; Zhu W; Li J
    Biol Pharm Bull; 2018 Sep; 41(9):1423-1429. PubMed ID: 29899181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction.
    Wang F; Schwarz BT; Graham WV; Wang Y; Su L; Clayburgh DR; Abraham C; Turner JR
    Gastroenterology; 2006 Oct; 131(4):1153-63. PubMed ID: 17030185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway.
    Du J; Chen Y; Shi Y; Liu T; Cao Y; Tang Y; Ge X; Nie H; Zheng C; Li YC
    Inflamm Bowel Dis; 2015 Nov; 21(11):2495-506. PubMed ID: 26287999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.
    Su L; Shen L; Clayburgh DR; Nalle SC; Sullivan EA; Meddings JB; Abraham C; Turner JR
    Gastroenterology; 2009 Feb; 136(2):551-63. PubMed ID: 19027740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CD52 antibody impairs mouse-transplanted intestinal tight junctions.
    Shen B; Yu H; Yu T; Shen J; Meng N; Cai X
    J Surg Res; 2015 Jun; 196(2):278-84. PubMed ID: 25796109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.
    Nighot P; Al-Sadi R; Rawat M; Guo S; Watterson DM; Ma T
    Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G988-97. PubMed ID: 26514773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitis.
    Terabe F; Fujimoto M; Serada S; Shinzaki S; Iijima H; Tsujii M; Hayashi N; Nomura S; Kawahata H; Jang MH; Miyasaka M; Mihara M; Ohsugi Y; Kishimoto T; Naka T
    Inflamm Bowel Dis; 2011 Feb; 17(2):491-502. PubMed ID: 20602470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice.
    Mizoguchi E; Mizoguchi A; Takedatsu H; Cario E; de Jong YP; Ooi CJ; Xavier RJ; Terhorst C; Podolsky DK; Bhan AK
    Gastroenterology; 2002 Jan; 122(1):134-44. PubMed ID: 11781288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal Antibody Against Mature Interleukin-18 Ameliorates Colitis in Mice and Improves Epithelial Barrier Function.
    Ikegami S; Maeda K; Urano T; Mu J; Nakamura M; Yamamura T; Sawada T; Ishikawa E; Yamamoto K; Muto H; Oishi A; Iida T; Mizutani Y; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Ishigami M; Kawashima H
    Inflamm Bowel Dis; 2024 Aug; 30(8):1353-1366. PubMed ID: 38141180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models.
    Maerten P; Shen C; Colpaert S; Liu Z; Bullens DA; van Assche G; Penninckx F; Geboes K; Vanham G; Rutgeerts P; Ceuppens JL
    Clin Exp Immunol; 2004 Feb; 135(2):310-7. PubMed ID: 14738461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function.
    Sun J; Shen X; Dong J; Zhao J; Zuo L; Wang H; Li Y; Zhu W; Gong J; Li J
    Int Immunopharmacol; 2015 Dec; 29(2):423-432. PubMed ID: 26603637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.
    Yang M; Jia W; Wang D; Han F; Niu W; Zhang H; Shih DQ; Zhang X
    Dig Dis Sci; 2019 Jul; 64(7):1844-1856. PubMed ID: 30949903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial Nuclear Factor-x03BA;B Activation in Inflammatory Bowel Diseases and Colitis-Associated Carcinogenesis.
    Nagaishi T; Watabe T; Jose N; Tokai A; Fujii T; Matsuoka K; Nagahori M; Ohtsuka K; Watanabe M
    Digestion; 2016; 93(1):40-6. PubMed ID: 26789263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.